	US 11,938,216 B2
	Injectable compositions
Joseph T. Delaney, Jr., Minneapolis, MN (US); Samuel Raybin, Marlborough, MA (US); John Kummailil, Sherborn, MA (US); and Matthew B. Hollyer, Williamstown, VT (US)
Assigned to Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed by Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed on Jul. 20, 2017, as Appl. No. 15/655,320.
Claims priority of provisional application 62/365,205, filed on Jul. 21, 2016.
Prior Publication US 2018/0021252 A1, Jan. 25, 2018
Int. Cl. A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/36 (2006.01); A61B 5/00 (2006.01); A61B 5/055 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61B 90/00 (2016.01)

CPC A61K 9/0019 (2013.01) [A61K 47/02 (2013.01); A61K 47/36 (2013.01); A61B 5/055 (2013.01); A61B 5/6842 (2013.01); A61B 5/687 (2013.01); A61B 5/6871 (2013.01); A61B 5/6873 (2013.01); A61B 2017/00269 (2013.01); A61B 2017/00898 (2013.01); A61B 2017/00942 (2013.01); A61B 17/3478 (2013.01); A61B 2090/3908 (2016.02); A61B 2090/3933 (2016.02); A61B 2090/3937 (2016.02)]

15 Claims

1. A sterile injectable solution comprising water and a hydrophilic polymer having a color in the visible spectrum either as a result of reflection of incident visible light or as a result of absorption of incident radiation having a first wavelength and re-emission of light having a second wavelength, longer than the first wavelength, in the visible spectrum, the hydrophilic polymer comprising a polysaccharide gum, and the sterile injectable solution exhibiting decreasing viscosity under shear, wherein the hydrophilic polymer comprises a covalently attached dye molecule.